Patents/Assignees

XUANZHU BIOPHARMACEUTICAL CO., Ltd.

3 patents in portfolio

US12441717utility2025
Crystal Form of Polycyclic Anaplastic Lymphoma Kinase Inhibitor
0 cites
US12331038utility2025
Hexone Glucokinase Inhibitor and Use Thereof
0 cites
US12178807utility2024
Macrocyclic Tyrosine Kinase Inhibitor and Uses Thereof
0 cites